First BTTC Clinical Trial Results Get Presented

Dr. Gilbert was asked to present the results of the first clinical trial was completed by the BTTC at the recent meeting of the American Society of Clinical Oncology. This trial, known as the factorial study, was the first successful implementation of this novel clinical trial design for the brain tumor patient population.  By simultaneously evaluating 8 different treatment regimens, this factorial design is far more efficient than standard clinical trials that typically evaluated 1 or 2 different treatments.  This study was well received and was featured as a highlight of the ASCO meeting.    

The factorial study and Dr. Mark Gilbert’s abstracts.